Corporate Governance

Egetis is an innovative, unique, and integrated pharmaceutical drug development company, focusing on projects in late-stage development for treatment of serious rare/niche diseases with significant unmet medical needs in the orphan drug segment

Board committees

The Board of Directors has set up three committees: the audit committee, the remuneration committee and the market access committee. The Board of Directors has adopted rules of procedure for all committees.

Audit committee

The Audit Committee’s role is to monitor the company’s financial reporting, the efficiency of the company’s internal controls, internal auditing and risk management and keep informed of the auditing of the annual report and the consolidated accounts, review and monitor the impartiality and independence of the auditor. The audit committee shall also assist the nomination committee in proposals for resolutions on the election and remuneration of the auditor.

Remuneration committee

The Remuneration Committee shall prepare proposals regarding remuneration principles, remuneration and other terms of employment for the CEO and senior executives.

Market Access committee

The purpose and aim for the Committee is to ensure a comprehensive and well prepared and supervised go-to-market model to the Company´s products.



Contact us

Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden

Phone: +46 8 679 72 10